KIF23

From WikiMD's WELLNESSPEDIA


Overview[edit]

Illustration of Kinesin-6 and Kinesin-12

KIF23 is a member of the kinesin superfamily of motor proteins, specifically classified under the Kinesin-6 family. Kinesins are essential for intracellular transport and are involved in various cellular processes, including mitosis, meiosis, and cytokinesis. KIF23 plays a critical role in the proper segregation of chromosomes during cell division.

Structure[edit]

KIF23 is a large protein that contains a motor domain, which is responsible for its ATPase activity and interaction with microtubules. The protein also has a stalk region and a tail domain, which are involved in cargo binding and dimerization. The motor domain is highly conserved among kinesins, allowing KIF23 to convert chemical energy from ATP hydrolysis into mechanical work.

Function[edit]

KIF23 is primarily involved in the process of cytokinesis, the final step of cell division where the cytoplasm of a parental cell is divided into two daughter cells. It is a key component of the central spindle and the midbody, structures that are crucial for the successful completion of cytokinesis. KIF23 interacts with other proteins, such as PRC1 and MKLP1, to ensure the proper formation and function of the central spindle.

Mechanism of Action[edit]

KIF23 moves along microtubules in a plus-end directed manner, meaning it travels towards the growing end of the microtubule. This movement is powered by the hydrolysis of ATP, which induces conformational changes in the motor domain, allowing it to "walk" along the microtubule. During cytokinesis, KIF23 helps to organize the microtubules of the central spindle and facilitates the ingression of the cleavage furrow.

Clinical Significance[edit]

Mutations or dysregulation of KIF23 have been implicated in various diseases, including certain types of cancer. Overexpression of KIF23 has been observed in some tumors, suggesting a role in tumorigenesis. As a result, KIF23 is being studied as a potential target for cancer therapy.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=KIF23&oldid=6621024"